Codiak BioSciences, Inc. (NASDAQ:CDAK) Short Interest Up 25.6% in March

Codiak BioSciences, Inc. (NASDAQ:CDAK – Get Rating) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 173,800 shares, a growth of 25.6% from the February 28th total of 138,400 shares. Based on an average daily volume of 176,800 shares, the […]

Related Keywords

Alaska ,United States ,Codiak Biosciences ,Nasdaq ,Codiak Biosciences Company Profile ,Codiak Biosciences Inc ,Forefront Analytics ,Alaska Permanent Fund Corp ,Renaissance Technologies ,Get Rating ,Permanent Fund Corp ,Capital Management ,Rhumbline Advisers ,Biosciences Trading Down ,Codiak Biosciences Daily ,Nasdaq Cdak ,Ncdak ,Medical ,Stocks ,Options ,Put ,Call ,